Moricizine

CHEMBL1075 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

427.5 g/mol

LogP

3.0

Phase

4

This medication is used to treat certain types of irregular heartbeats by slowing electrical signals in the heart. It helps stabilize the heart's rhythm and is taken as a tablet, usually two to three times daily.

Moleküler Ağırlık

427,5000 g/mol

LogP

3,00

TPSA

96,40 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Atrial Fibrillation Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2

InChI

InChI=1S/C22H25N3O4S/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24/h3-8,15H,2,9-14H2,1H3,(H,23,27)

Molecular Formula

C22H25N3O4S

HBD / HBA

1 / 6

Döndürülebilir Bağlar

6

Ağır Atomlar

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication is used to treat certain types of irregular heartbeats by slowing electrical signals in the heart. It helps stabilize the heart's rhythm and is taken as a tablet, usually two to three times daily.

Yes, Moricizine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1075. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 34633. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Moricizine PillFYI'da

Yapı

Hızlı Veriler

Formül: C22H25N3O4S

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.